Manager × security

PARADIGM CAPITAL MANAGEMENT INC/NY GMED holdings history

Who else holds this security? →

GLOBUS MEDICAL INC - A · CUSIP 379577208 · CIK 1037792

This is the oldest quarter open without an account, so changes against the quarter before it are withheld. Sign in to see them.
Citable facts

As of 2026-06-30, PARADIGM CAPITAL MANAGEMENT INC/NY reported 886.50K GMED (shares), valued at $70.04M, or 1.91% of its reported non-derivative portfolio. Filed 2026-08-13.

Verify history & sources →
Portfolio weight and quantity history
Reported portfolio weight
1.91%
Shares
886.50K
886,499
Reported value
$70.04M
USD

Shares increased 7.81%; reported value decreased 1.14%, and weight changed -0.80 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.

Left: % · Right: Shares · Independently scaled axes

Exact data and methodology

Axes scale independently; a crossing does not mean equal values. Weight uses each quarter's total reported non-derivative value. Same CUSIP; missing quarters are gaps, not zero. Revised history may include later disclosures.

QuarterWeightQuantitySource
Q2 20261.91%886,499SEC filing ↗Filed Aug 13, 2026
Q1 20262.71%822,299SEC filing ↗Filed May 14, 2026
Q4 20253.48%945,799SEC filing ↗Filed Feb 12, 2026
Q3 20252.35%946,800SEC filing ↗Filed Nov 14, 2025
Q2 20252.71%942,300SEC filing ↗Filed Aug 14, 2025
Q1 20253.86%949,300SEC filing ↗Filed May 15, 2025
Q4 20243.64%949,300SEC filing ↗Filed Feb 18, 2025
Q3 20243.08%971,400SEC filing ↗Filed Nov 14, 2024
Q2 20243.13%1,001,400SEC filing ↗Filed Aug 14, 2024
Q1 20242.60%1,011,400SEC filing ↗Filed May 15, 2024
Q4 20232.75%991,800SEC filing ↗Filed Feb 13, 2024
Q3 20232.80%984,100SEC filing ↗Filed Nov 13, 2023

History & evidence by quarter

QuarterWeightQuantityValueChange explainedSource
Q3 20232.80%984,100$48.86MThe prior quarter is outside the free window. Sign in for the comparison.SEC filing ↗
Filed Nov 13, 2023
Q4 20232.75%991,800$52.85MShares increased 0.78%; reported value increased 8.17%, and weight changed -0.05 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 13, 2024
Q1 20242.60%1,011,400$54.25MShares increased 1.98%; reported value increased 2.65%, and weight changed -0.15 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 15, 2024
Q2 20243.13%1,001,400$68.59MShares decreased 0.99%; reported value increased 26.42%, and weight changed +0.53 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 14, 2024
Q3 20243.08%971,400$69.49MShares decreased 3.00%; reported value increased 1.32%, and weight changed -0.05 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 14, 2024
Q4 20243.64%949,300$78.52MShares decreased 2.28%; reported value increased 12.98%, and weight changed +0.56 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 18, 2025
Q1 20253.86%949,300$69.49MShares unchanged; reported value decreased 11.50%, and weight changed +0.22 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 15, 2025
Q2 20252.71%942,300$55.61MShares decreased 0.74%; reported value decreased 19.97%, and weight changed -1.15 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 14, 2025
Q3 20252.35%946,800$54.22MShares increased 0.48%; reported value decreased 2.50%, and weight changed -0.36 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 14, 2025
Q4 20253.48%945,799$82.58MShares decreased 0.11%; reported value increased 52.29%, and weight changed +1.13 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 12, 2026
Q1 20262.71%822,299$70.85MShares decreased 13.06%; reported value decreased 14.20%, and weight changed -0.77 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 14, 2026
Q2 20261.91%886,499$70.04MShares increased 7.81%; reported value decreased 1.14%, and weight changed -0.80 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 13, 2026
PARADIGM CAPITAL MANAGEMENT INC/NY · GLOBUS MEDICAL INC - A

Take these holdings further.

This page includes 12 of 12 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.

  • Download CSV
  • Earlier quarters
  • Advanced screening & filtering
  • API & AI access
Already have an account?

+ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.

MCP  https://api.akkrudata.ai/mcp

get_institutional_portfolio
{"cik":"1037792","quarter":"2026Q2","cusip":"379577208"}

get_institutional_manager_history
{"cik":"1037792","page_size":100}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint
https://api.akkrudata.ai/mcp
API / MCP documentation
/documents
llms.txt
/llms.txt
Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

13F reports quarter-end long positions in securities traded on US exchanges, filed by managers holding at least $100 million of such securities; it is not the manager's full portfolio, not assets under management, and value changes are not returns. Weights use the reported total value as denominator. Option rows show notional value, not premium or net exposure. Amendments are merged into the quarter when Akkru could match them.